Steven L Barriere

Title: The Innovations of Steven L. Barriere

Introduction

Steven L. Barriere is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of infections. His work has led to the development of innovative methods for administering telavancin, a critical antibiotic.

Latest Patents

Barriere holds a patent for "Doses and methods for administering telavancin." This patent outlines the administration of telavancin or its pharmaceutically-acceptable salts to human patients suffering from various infections, including bacteremia, pneumonia, endocarditis, osteomyelitis, and complicated skin and skin structure infections. The patent emphasizes that the dosage of telavancin is determined by the patient's weight and creatinine clearance, ensuring tailored treatment for optimal efficacy.

Career Highlights

Throughout his career, Barriere has worked with prominent companies in the pharmaceutical industry. He has been associated with Cumberland Pharmaceuticals, Inc. and Theravance Biopharma Antibiotics IP, LLC. His experience in these organizations has contributed to his expertise in antibiotic development and patient care.

Collaborations

Barriere has collaborated with esteemed professionals in the field, including Arthur Lo and Mathai Mammen. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in antibiotic therapies.

Conclusion

Steven L. Barriere's contributions to the field of pharmaceuticals, particularly through his patent on telavancin administration, highlight his role as an influential inventor. His work continues to impact the treatment of serious infections, showcasing the importance of innovation in healthcare.